Abbott Laboratories
ABT
$113.58
-$0.03-0.03%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 8.94B | 7.73B | 7.28B | 6.84B | 7.97B |
| Total Receivables | 7.93B | 8.14B | 7.97B | 7.33B | 6.93B |
| Inventory | 6.49B | 6.71B | 6.95B | 6.64B | 6.19B |
| Prepaid Expenses | 2.53B | 2.21B | 2.15B | 2.16B | 2.18B |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 108.00M | 55.00M | 111.00M | 188.00M | 390.00M |
| Total Current Assets | 26.00B | 24.84B | 24.47B | 23.15B | 23.66B |
|
|
|||||
| Total Current Assets | 26.00B | 24.84B | 24.47B | 23.15B | 23.66B |
| Net Property, Plant & Equipment | 12.94B | 11.50B | 11.40B | 10.93B | 11.73B |
| Long-term Investments | 24.04B | 23.97B | 23.95B | 23.36B | 23.11B |
| Goodwill | 24.04B | 23.97B | 23.95B | 23.36B | 23.11B |
| Total Other Intangibles | 5.53B | 5.60B | 5.92B | 6.26B | 6.65B |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 17.62B | 17.64B | 17.62B | 17.14B | 15.70B |
| Total Assets | 86.71B | 84.18B | 84.00B | 81.45B | 81.41B |
|
|
|||||
| Total Accounts Payable | 4.24B | 4.12B | 4.31B | 4.21B | 4.20B |
| Total Accrued Expenses | 7.17B | 7.31B | 6.81B | 6.56B | 6.20B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.31B | 1.35B | 507.00M | 506.00M | 1.75B |
| Total Finance Division Other Current Liabilities | 1.77B | 1.80B | 1.82B | 1.73B | 2.01B |
| Total Other Current Liabilities | 1.77B | 1.80B | 1.82B | 1.73B | 2.01B |
| Total Current Liabilities | 16.50B | 14.58B | 13.44B | 13.00B | 14.16B |
|
|
|||||
| Total Current Liabilities | 16.50B | 14.58B | 13.44B | 13.00B | 14.16B |
| Long-Term Debt | 9.90B | 11.63B | 12.96B | 12.78B | 12.68B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 931.00M | -- | -- | -- | 896.00M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 6.62B | 6.71B | 6.77B | 6.60B | 5.78B |
| Total Liabilities | 33.94B | 32.92B | 33.17B | 32.38B | 33.51B |
|
|
|||||
| Common Stock & APIC | 25.53B | 25.41B | 25.28B | 25.13B | 25.15B |
| Retained Earnings | 49.78B | 49.10B | 48.47B | 47.72B | 47.26B |
| Treasury Stock & Other | -23.18B | -23.56B | -23.19B | -24.03B | -24.75B |
| Total Common Equity | 52.13B | 50.95B | 50.57B | 48.81B | 47.66B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 52.13B | 50.95B | 50.57B | 48.81B | 47.66B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 641.00M | 310.00M | 264.00M | 253.00M | 237.00M |
| Total Equity | 52.77B | 51.26B | 50.83B | 49.06B | 47.90B |
|
|
|||||